IL-6 is a pleiotropic cytokine that can exert different and opposite effects. The muscle-induced and transient expression of IL-6 can act in an autocrine or paracrine manner, stimulating anabolic pathways associated with muscle growth, myogenesis, and with regulation of energy metabolism. In contrast, under pathologic conditions, including muscular dystrophy, cancer associated cachexia, aging, chronic inflammatory diseases, and other pathologies, the plasma levels of IL-6 significantly increase, promoting muscle wasting. Nevertheless, the specific physio-pathological role exerted by IL-6 in the maintenance of differentiated phenotype remains to be addressed. The purpose of this study was to define the role of increased plasma levels of IL-6 on muscle homeostasis and the mechanisms contributing to muscle loss. Here, we reported that increased plasma levels of IL-6 promote alteration in muscle growth at early stage of postnatal life and induce muscle wasting by triggering a shift of the slow-twitch fibers toward a more sensitive fast fiber phenotype. These findings unveil a role for IL-6 as a potential biomarker of stunted growth and skeletal muscle wasting.

Sustained systemic levels of IL-6 impinge early muscle growth and induce muscle atrophy and wasting in adulthood / Pelosi, L.; Berardinelli, M. G.; Forcina, L.; Ascenzi, F.; Rizzuto, E.; Sandri, M.; De Benedetti, F.; Scicchitano, B. M.; Musarò, Antonio.. - In: CELLS. - ISSN 2073-4409. - 10:7(2021), pp. 1-15. [10.3390/cells10071816]

Sustained systemic levels of IL-6 impinge early muscle growth and induce muscle atrophy and wasting in adulthood

Forcina L.;Ascenzi F.;Rizzuto E.;Musarò Antonio.
2021

Abstract

IL-6 is a pleiotropic cytokine that can exert different and opposite effects. The muscle-induced and transient expression of IL-6 can act in an autocrine or paracrine manner, stimulating anabolic pathways associated with muscle growth, myogenesis, and with regulation of energy metabolism. In contrast, under pathologic conditions, including muscular dystrophy, cancer associated cachexia, aging, chronic inflammatory diseases, and other pathologies, the plasma levels of IL-6 significantly increase, promoting muscle wasting. Nevertheless, the specific physio-pathological role exerted by IL-6 in the maintenance of differentiated phenotype remains to be addressed. The purpose of this study was to define the role of increased plasma levels of IL-6 on muscle homeostasis and the mechanisms contributing to muscle loss. Here, we reported that increased plasma levels of IL-6 promote alteration in muscle growth at early stage of postnatal life and induce muscle wasting by triggering a shift of the slow-twitch fibers toward a more sensitive fast fiber phenotype. These findings unveil a role for IL-6 as a potential biomarker of stunted growth and skeletal muscle wasting.
2021
interleukin-6; muscle atrophy; muscle growth; PGC-1α; skeletal muscle
01 Pubblicazione su rivista::01a Articolo in rivista
Sustained systemic levels of IL-6 impinge early muscle growth and induce muscle atrophy and wasting in adulthood / Pelosi, L.; Berardinelli, M. G.; Forcina, L.; Ascenzi, F.; Rizzuto, E.; Sandri, M.; De Benedetti, F.; Scicchitano, B. M.; Musarò, Antonio.. - In: CELLS. - ISSN 2073-4409. - 10:7(2021), pp. 1-15. [10.3390/cells10071816]
File allegati a questo prodotto
File Dimensione Formato  
Pelosi_Sustained-systemic-levels_2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 2.55 MB
Formato Adobe PDF
2.55 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1573634
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 8
social impact